Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,050.00    10.00 (0.14%)
Bid:
7,045.00
Ask:
7,055.00
Spread: 10.00 (0.142%)
Market Cap: £9.45b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Director/PDMR Shareholding

22 Dec 2025 07:00

RNS Number : 3505M
Diploma PLC
22 December 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EETELEPHONE: +44 (0)20 7549 5700

 

22 December 2025

 

Director/PDMR Shareholding and Long Term Incentive Award

 

Diploma PLC (the "Company") announces that on 19 December 2025, Wilson Ng, Chief Financial Officer, acquired a beneficial interest in 410 Ordinary Shares in the Company at £53.69 per share. Following this transaction, Wilson's total shareholding is 5,397 Ordinary Shares.

The shares were purchased using an amount equal to 50% of Wilson's annual bonus, net of tax, awarded for FY2025. These shares will be held under restriction in accordance with the Company's Shareholding Policy.The Company further announces that the Remuneration Committee has approved the grant of a long-term incentive award (the "Award") to Wilson on 19 December 2025 under the Diploma PLC 2020 Performance Share Plan (as amended) ("PSP"). A total of 12,289 Ordinary Shares were awarded at a share price of £53.40.

The Award is subject to the achievement of performance conditions measured over a three-year period ending 30 September 2028.The number of shares stated above represents the maximum that may vest in connection with this Award.

A summary of the PSP, including the performance conditions applicable to this Award, is provided in the Company's Annual Report and Accounts 2025.

The Notification of Dealing Form for both transactions can be found below. This announcement is made in accordance with the UK Market Abuse Regulation.

 

1

Details of the Director/PDMR/PCA

a)

Name

Wilson Ng

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer

a)

Name

Diploma PLC

b)

LEI

2138008OGI7VYG8FGR19

4

Details of the transactions:

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 5p each in the Company

 

 

GB0001826634

b)

Nature of the transaction

1) Purchase of shares

2) Grant of PSP shares

c)

Price(s) and volume(s)

 

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

e)

Date of the transaction

19 December 2025

f)

Place of the transaction

1. London Stock Exchange

2. Outside a trading venue

 

For further information please contact:

Diploma PLC

Tel: +44 (0)20 7549 5700

Anna Lawrence, Group General Counsel & Company Secretary

 

LEI: 2138008OGI7VYG8FGR19

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMMZKLNGKZM
Date   Source Headline
16th Jan 202010:40 amRNSResult of AGM
15th Jan 20207:00 amRNSTrading Statement
24th Dec 20197:00 amRNSDirector / PDMR Grant of LTIP Award
23rd Dec 20197:00 amRNSDirectorate Change
17th Dec 20195:09 pmRNSHolding(s) in Company
16th Dec 201912:00 pmRNSHolding(s) in Company
6th Dec 20193:27 pmRNSAnnual Financial Report & Notice of AGM
21st Nov 20194:00 pmRNSDirector/PDMR Shareholding
18th Nov 20197:00 amRNSFinal Results
8th Oct 20197:00 amRNSDirectorate Change
25th Sep 20197:00 amRNSAcquisition
10th Sep 20194:49 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSTrading Statement
8th Aug 20193:00 pmRNSHolding(s) in Company
17th Jul 20191:01 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSAcquisition
13th Jun 20192:00 pmRNSDirector Declaration
13th May 20197:00 amRNSHalf-year Report
1st Apr 20197:00 amRNSAppointment of Joint Corporate Broker
27th Mar 20197:00 amRNSHalf Year Trading Update
26th Feb 20197:00 amRNSDirector/PDMR Shareholding
25th Feb 20194:00 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSDirectorate Appointments
29th Jan 20193:30 pmRNSDirector/PDMR Shareholding
16th Jan 20194:19 pmRNSResult of AGM
16th Jan 20197:01 amRNSDirectorate Change
16th Jan 20197:00 amRNSTrading Statement
7th Dec 20184:09 pmRNSDirector/PDMR Shareholding
7th Dec 20183:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20184:26 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSFinal Results
12th Oct 20187:00 amRNSAcquisition
3rd Sep 20184:45 pmRNSBoard Committee Change
29th Aug 20187:01 amRNSDirectorate Change
29th Aug 20187:00 amRNSTrading Statement
22nd Aug 20187:00 amRNSAcquisition
10th Jul 20181:46 pmRNSHolding(s) in Company
12th Jun 20182:59 pmRNSHolding(s) in Company
16th May 20182:41 pmRNSDirector Declaration
15th May 20184:20 pmRNSDirector/PDMR Shareholding
15th May 20184:09 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSHalf-year Report
9th May 20187:00 amRNSDirectorate Change
23rd Apr 20187:00 amRNSDirectorate Change
28th Mar 20187:00 amRNSTrading Update
21st Mar 20189:30 amRNSHolding(s) in Company
20th Mar 20184:00 pmRNSHolding(s) in Company
6th Feb 20189:49 amRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSDirectorate Change
23rd Jan 20184:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.